primers for sequenom massarray iplex (Sequenom)
90
Structured Review
Sequenom
primers for sequenom massarray iplex
Primers For Sequenom Massarray Iplex, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primers+for+sequenom+massarray+iplex+assays/primers+for+sequenom+analysis/pmc07052880__jcav11p1985s1-2-2-4
Average 90 stars, based on 1 article reviews
Primers For Sequenom Massarray Iplex, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primers+for+sequenom+massarray+iplex+assays/primers+for+sequenom+analysis/pmc07052880__jcav11p1985s1-2-2-4
Average 90 stars, based on 1 article reviews
primers for sequenom massarray iplex - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Sequencing:Article Title: An intronic genetic variation of <em>MGMT</em> affects enhancer activity and is associated with glioma susceptibility Article Snippet: Table S1 information of primers for sequenom MassaRRaY iPleX assays Variants Primer Sequence (5′-3′) rs10764901 second PCR primer aCgTTggaTgCTgaaaagaggaagagaCgC First PCR primer aCgTTggaTgagagaCaCgTCaggaCTTaC extend primer aCgCgaaTTTTCTaTgaaaagTa rs577227 second PCR primer aCgTTggaTgagTaTaaaCaggaaCggagC First PCR primer aCgTTggaTgagggCaCTTgaaaTgCTgaC extend primer ggggCagaCaggCaggCag Table S2 information of probes for electrophoretic mobility shift assays Probe Sequence (5′-3′) Probe-g gcttgcccaagacatgtacttttcatagaaa-biotin Probe-a gcttgcccaagacatatacttttcatagaaa-biotin non-labeled g gcttgcccaagacatgtacttttcatagaaa non-labeled a gcttgcccaagacatatacttttcatagaaa non-labeled mut gcttgcccaagacatctacttttcatagaaa Table S3 genotype frequencies of rs10764901 genotyped using blood Dna or adjacent normal tissue Dna in glioma patients Genotype Blood (n=138) No. (%) Tissue (n=12) No. (%) P-value gg 72 (52.17) 7 (58.33) 0.371a ag 56 (40.58) 3 (25.00) aa 10 (7.25) 2 (16.67) Notes: aTwo-sided χ2 test. Article Title: Genetic variants in vitamin D signaling pathways and risk of gestational diabetes mellitus Article Snippet: Table S3 Information of primers for Sequenom MassARRAY iPLEX assays SNP_ID 2nd-PCR Primer 1st-PCR Primer Extend Primer rs166899 ACGTTGGATGTCCAGCTCACTGTAGCTAAC ACGTTGGATGACTGCAGCAATGCTTTGCTC CCTTTTTTCCAGTGTCATCT rs16847024 ACGTTGGATGCACTGGGTAAATTCTGTGAC ACGTTGGATGAACCAGGAGTGGAACTCATC GAGAGTCATAGGTAGATCATT rs17429130 ACGTTGGATGACTTTCTGGAAGTTCTTGGG ACGTTGGATGCATTTGTTTGCTTTCCAGGG ATGGAAGTTCTTGGGAAAACTAAT rs1805343 ACGTTGGATGAGCAAGAGCTTAGCGAACCT ACGTTGGATGTCCAGTGCCAGGGCAGAACT AAAAGGTCTGGTGAGGGC rs2248137 ACGTTGGATGATGGTGCGCTTCGGCGTCT ACGTTGGATGATCCTCCGCCGTGCCCGAA TCGGCGTCTGGGCAG rs2259735 ACGTTGGATGTTCTCTGGCTATTTCTTGGC ACGTTGGATGAGAAATACTCCAGCTGCAAC GGGTCTATTTCTTGGCATGATTCTC rs28465650 ACGTTGGATGGGGAGTGTTTTACAGAATC ACGTTGGATGAGGAGAGCATTCTCGGTGTG GTTTTACAGAATCTCAGCA rs34835001 ACGTTGGATGTTCCAGCTGCTGCCCGATTT ACGTTGGATGAGAGCACGAGGGTATGACAG GACACCGTCTGTGTGTG rs3818740 ACGTTGGATGTTTTTCCCAGGCTTCCTGAG ACGTTGGATGTCTCTAAGTCAAGCGAGTCC GATGAGGCGAGGGCATCC rs4341603 ACGTTGGATGGGCTGAATTTTTCAGGTCTC ACGTTGGATGCCTTCAGGGAGATCCTTAAC CAAGTTTTCAGGTCTCTCCTTTA rs4646536 ACGTTGGATGGTTGGAAACAATGAGAAGGG ACGTTGGATGCAGTCTAGGTTGCAAAGCAC CCCTAGCCTCATCTTG rs4674343 ACGTTGGATGCAGAACCAGAATATTGACCC ACGTTGGATGCTGCCTGCTCCTGTGAACC AGGTACCCAGATTTTTACATTATCC rs4917356 ACGTTGGATGGGGTGATCTGCTTGTCCAGT ACGTTGGATGTGAAACTCATCCCCACTGTC GCTTGTCCAGTGGTTTC rs7136534 ACGTTGGATGTTCTCAGGAACCAACTGCCG ACGTTGGATGGAGAGTCCTGGTCCTAAGCA CACTCCGCTTTCCCGC rs739837 ACGTTGGATGCTGTTCCCTCAACATCAGTC ACGTTGGATGAGGGCCTTGCCCAGAGATG GGGAAGTCAGCAGCCACTTA Polymerase Chain Reaction:Article Title: An intronic genetic variation of <em>MGMT</em> affects enhancer activity and is associated with glioma susceptibility Article Snippet: Table S1 information of primers for sequenom MassaRRaY iPleX assays Variants Primer Sequence (5′-3′) rs10764901 second PCR primer aCgTTggaTgCTgaaaagaggaagagaCgC First PCR primer aCgTTggaTgagagaCaCgTCaggaCTTaC extend primer aCgCgaaTTTTCTaTgaaaagTa rs577227 second PCR primer aCgTTggaTgagTaTaaaCaggaaCggagC First PCR primer aCgTTggaTgagggCaCTTgaaaTgCTgaC extend primer ggggCagaCaggCaggCag Table S2 information of probes for electrophoretic mobility shift assays Probe Sequence (5′-3′) Probe-g gcttgcccaagacatgtacttttcatagaaa-biotin Probe-a gcttgcccaagacatatacttttcatagaaa-biotin non-labeled g gcttgcccaagacatgtacttttcatagaaa non-labeled a gcttgcccaagacatatacttttcatagaaa non-labeled mut gcttgcccaagacatctacttttcatagaaa Table S3 genotype frequencies of rs10764901 genotyped using blood Dna or adjacent normal tissue Dna in glioma patients Genotype Blood (n=138) No. (%) Tissue (n=12) No. (%) P-value gg 72 (52.17) 7 (58.33) 0.371a ag 56 (40.58) 3 (25.00) aa 10 (7.25) 2 (16.67) Notes: aTwo-sided χ2 test. Article Title: Genetic variants in vitamin D signaling pathways and risk of gestational diabetes mellitus Article Snippet: Table S3 Information of primers for Sequenom MassARRAY iPLEX assays SNP_ID 2nd-PCR Primer 1st-PCR Primer Extend Primer rs166899 ACGTTGGATGTCCAGCTCACTGTAGCTAAC ACGTTGGATGACTGCAGCAATGCTTTGCTC CCTTTTTTCCAGTGTCATCT rs16847024 ACGTTGGATGCACTGGGTAAATTCTGTGAC ACGTTGGATGAACCAGGAGTGGAACTCATC GAGAGTCATAGGTAGATCATT rs17429130 ACGTTGGATGACTTTCTGGAAGTTCTTGGG ACGTTGGATGCATTTGTTTGCTTTCCAGGG ATGGAAGTTCTTGGGAAAACTAAT rs1805343 ACGTTGGATGAGCAAGAGCTTAGCGAACCT ACGTTGGATGTCCAGTGCCAGGGCAGAACT AAAAGGTCTGGTGAGGGC rs2248137 ACGTTGGATGATGGTGCGCTTCGGCGTCT ACGTTGGATGATCCTCCGCCGTGCCCGAA TCGGCGTCTGGGCAG rs2259735 ACGTTGGATGTTCTCTGGCTATTTCTTGGC ACGTTGGATGAGAAATACTCCAGCTGCAAC GGGTCTATTTCTTGGCATGATTCTC rs28465650 ACGTTGGATGGGGAGTGTTTTACAGAATC ACGTTGGATGAGGAGAGCATTCTCGGTGTG GTTTTACAGAATCTCAGCA rs34835001 ACGTTGGATGTTCCAGCTGCTGCCCGATTT ACGTTGGATGAGAGCACGAGGGTATGACAG GACACCGTCTGTGTGTG rs3818740 ACGTTGGATGTTTTTCCCAGGCTTCCTGAG ACGTTGGATGTCTCTAAGTCAAGCGAGTCC GATGAGGCGAGGGCATCC rs4341603 ACGTTGGATGGGCTGAATTTTTCAGGTCTC ACGTTGGATGCCTTCAGGGAGATCCTTAAC CAAGTTTTCAGGTCTCTCCTTTA rs4646536 ACGTTGGATGGTTGGAAACAATGAGAAGGG ACGTTGGATGCAGTCTAGGTTGCAAAGCAC CCCTAGCCTCATCTTG rs4674343 ACGTTGGATGCAGAACCAGAATATTGACCC ACGTTGGATGCTGCCTGCTCCTGTGAACC AGGTACCCAGATTTTTACATTATCC rs4917356 ACGTTGGATGGGGTGATCTGCTTGTCCAGT ACGTTGGATGTGAAACTCATCCCCACTGTC GCTTGTCCAGTGGTTTC rs7136534 ACGTTGGATGTTCTCAGGAACCAACTGCCG ACGTTGGATGGAGAGTCCTGGTCCTAAGCA CACTCCGCTTTCCCGC rs739837 ACGTTGGATGCTGTTCCCTCAACATCAGTC ACGTTGGATGAGGGCCTTGCCCAGAGATG GGGAAGTCAGCAGCCACTTA Electrophoretic Mobility Shift Assay:Article Title: An intronic genetic variation of <em>MGMT</em> affects enhancer activity and is associated with glioma susceptibility Article Snippet: Table S1 information of primers for sequenom MassaRRaY iPleX assays Variants Primer Sequence (5′-3′) rs10764901 second PCR primer aCgTTggaTgCTgaaaagaggaagagaCgC First PCR primer aCgTTggaTgagagaCaCgTCaggaCTTaC extend primer aCgCgaaTTTTCTaTgaaaagTa rs577227 second PCR primer aCgTTggaTgagTaTaaaCaggaaCggagC First PCR primer aCgTTggaTgagggCaCTTgaaaTgCTgaC extend primer ggggCagaCaggCaggCag Table S2 information of probes for electrophoretic mobility shift assays Probe Sequence (5′-3′) Probe-g gcttgcccaagacatgtacttttcatagaaa-biotin Probe-a gcttgcccaagacatatacttttcatagaaa-biotin non-labeled g gcttgcccaagacatgtacttttcatagaaa non-labeled a gcttgcccaagacatatacttttcatagaaa non-labeled mut gcttgcccaagacatctacttttcatagaaa Table S3 genotype frequencies of rs10764901 genotyped using blood Dna or adjacent normal tissue Dna in glioma patients Genotype Blood (n=138) No. (%) Tissue (n=12) No. (%) P-value gg 72 (52.17) 7 (58.33) 0.371a ag 56 (40.58) 3 (25.00) aa 10 (7.25) 2 (16.67) Notes: aTwo-sided χ2 test. Article Title: Genetic variants in vitamin D signaling pathways and risk of gestational diabetes mellitus Article Snippet: Table S3 Information of primers for Sequenom MassARRAY iPLEX assays SNP_ID 2nd-PCR Primer 1st-PCR Primer Extend Primer rs166899 ACGTTGGATGTCCAGCTCACTGTAGCTAAC ACGTTGGATGACTGCAGCAATGCTTTGCTC CCTTTTTTCCAGTGTCATCT rs16847024 ACGTTGGATGCACTGGGTAAATTCTGTGAC ACGTTGGATGAACCAGGAGTGGAACTCATC GAGAGTCATAGGTAGATCATT rs17429130 ACGTTGGATGACTTTCTGGAAGTTCTTGGG ACGTTGGATGCATTTGTTTGCTTTCCAGGG ATGGAAGTTCTTGGGAAAACTAAT rs1805343 ACGTTGGATGAGCAAGAGCTTAGCGAACCT ACGTTGGATGTCCAGTGCCAGGGCAGAACT AAAAGGTCTGGTGAGGGC rs2248137 ACGTTGGATGATGGTGCGCTTCGGCGTCT ACGTTGGATGATCCTCCGCCGTGCCCGAA TCGGCGTCTGGGCAG rs2259735 ACGTTGGATGTTCTCTGGCTATTTCTTGGC ACGTTGGATGAGAAATACTCCAGCTGCAAC GGGTCTATTTCTTGGCATGATTCTC rs28465650 ACGTTGGATGGGGAGTGTTTTACAGAATC ACGTTGGATGAGGAGAGCATTCTCGGTGTG GTTTTACAGAATCTCAGCA rs34835001 ACGTTGGATGTTCCAGCTGCTGCCCGATTT ACGTTGGATGAGAGCACGAGGGTATGACAG GACACCGTCTGTGTGTG rs3818740 ACGTTGGATGTTTTTCCCAGGCTTCCTGAG ACGTTGGATGTCTCTAAGTCAAGCGAGTCC GATGAGGCGAGGGCATCC rs4341603 ACGTTGGATGGGCTGAATTTTTCAGGTCTC ACGTTGGATGCCTTCAGGGAGATCCTTAAC CAAGTTTTCAGGTCTCTCCTTTA rs4646536 ACGTTGGATGGTTGGAAACAATGAGAAGGG ACGTTGGATGCAGTCTAGGTTGCAAAGCAC CCCTAGCCTCATCTTG rs4674343 ACGTTGGATGCAGAACCAGAATATTGACCC ACGTTGGATGCTGCCTGCTCCTGTGAACC AGGTACCCAGATTTTTACATTATCC rs4917356 ACGTTGGATGGGGTGATCTGCTTGTCCAGT ACGTTGGATGTGAAACTCATCCCCACTGTC GCTTGTCCAGTGGTTTC rs7136534 ACGTTGGATGTTCTCAGGAACCAACTGCCG ACGTTGGATGGAGAGTCCTGGTCCTAAGCA CACTCCGCTTTCCCGC rs739837 ACGTTGGATGCTGTTCCCTCAACATCAGTC ACGTTGGATGAGGGCCTTGCCCAGAGATG GGGAAGTCAGCAGCCACTTA Significance Assay:Article Title: An intronic genetic variation of <em>MGMT</em> affects enhancer activity and is associated with glioma susceptibility Article Snippet: Table S1 information of primers for sequenom MassaRRaY iPleX assays Variants Primer Sequence (5′-3′) rs10764901 second PCR primer aCgTTggaTgCTgaaaagaggaagagaCgC First PCR primer aCgTTggaTgagagaCaCgTCaggaCTTaC extend primer aCgCgaaTTTTCTaTgaaaagTa rs577227 second PCR primer aCgTTggaTgagTaTaaaCaggaaCggagC First PCR primer aCgTTggaTgagggCaCTTgaaaTgCTgaC extend primer ggggCagaCaggCaggCag Table S2 information of probes for electrophoretic mobility shift assays Probe Sequence (5′-3′) Probe-g gcttgcccaagacatgtacttttcatagaaa-biotin Probe-a gcttgcccaagacatatacttttcatagaaa-biotin non-labeled g gcttgcccaagacatgtacttttcatagaaa non-labeled a gcttgcccaagacatatacttttcatagaaa non-labeled mut gcttgcccaagacatctacttttcatagaaa Table S3 genotype frequencies of rs10764901 genotyped using blood Dna or adjacent normal tissue Dna in glioma patients Genotype Blood (n=138) No. (%) Tissue (n=12) No. (%) P-value gg 72 (52.17) 7 (58.33) 0.371a ag 56 (40.58) 3 (25.00) aa 10 (7.25) 2 (16.67) Notes: aTwo-sided χ2 test. Article Title: Genetic variants in vitamin D signaling pathways and risk of gestational diabetes mellitus Article Snippet: Table S3 Information of primers for Sequenom MassARRAY iPLEX assays SNP_ID 2nd-PCR Primer 1st-PCR Primer Extend Primer rs166899 ACGTTGGATGTCCAGCTCACTGTAGCTAAC ACGTTGGATGACTGCAGCAATGCTTTGCTC CCTTTTTTCCAGTGTCATCT rs16847024 ACGTTGGATGCACTGGGTAAATTCTGTGAC ACGTTGGATGAACCAGGAGTGGAACTCATC GAGAGTCATAGGTAGATCATT rs17429130 ACGTTGGATGACTTTCTGGAAGTTCTTGGG ACGTTGGATGCATTTGTTTGCTTTCCAGGG ATGGAAGTTCTTGGGAAAACTAAT rs1805343 ACGTTGGATGAGCAAGAGCTTAGCGAACCT ACGTTGGATGTCCAGTGCCAGGGCAGAACT AAAAGGTCTGGTGAGGGC rs2248137 ACGTTGGATGATGGTGCGCTTCGGCGTCT ACGTTGGATGATCCTCCGCCGTGCCCGAA TCGGCGTCTGGGCAG rs2259735 ACGTTGGATGTTCTCTGGCTATTTCTTGGC ACGTTGGATGAGAAATACTCCAGCTGCAAC GGGTCTATTTCTTGGCATGATTCTC rs28465650 ACGTTGGATGGGGAGTGTTTTACAGAATC ACGTTGGATGAGGAGAGCATTCTCGGTGTG GTTTTACAGAATCTCAGCA rs34835001 ACGTTGGATGTTCCAGCTGCTGCCCGATTT ACGTTGGATGAGAGCACGAGGGTATGACAG GACACCGTCTGTGTGTG rs3818740 ACGTTGGATGTTTTTCCCAGGCTTCCTGAG ACGTTGGATGTCTCTAAGTCAAGCGAGTCC GATGAGGCGAGGGCATCC rs4341603 ACGTTGGATGGGCTGAATTTTTCAGGTCTC ACGTTGGATGCCTTCAGGGAGATCCTTAAC CAAGTTTTCAGGTCTCTCCTTTA rs4646536 ACGTTGGATGGTTGGAAACAATGAGAAGGG ACGTTGGATGCAGTCTAGGTTGCAAAGCAC CCCTAGCCTCATCTTG rs4674343 ACGTTGGATGCAGAACCAGAATATTGACCC ACGTTGGATGCTGCCTGCTCCTGTGAACC AGGTACCCAGATTTTTACATTATCC rs4917356 ACGTTGGATGGGGTGATCTGCTTGTCCAGT ACGTTGGATGTGAAACTCATCCCCACTGTC GCTTGTCCAGTGGTTTC rs7136534 ACGTTGGATGTTCTCAGGAACCAACTGCCG ACGTTGGATGGAGAGTCCTGGTCCTAAGCA CACTCCGCTTTCCCGC rs739837 ACGTTGGATGCTGTTCCCTCAACATCAGTC ACGTTGGATGAGGGCCTTGCCCAGAGATG GGGAAGTCAGCAGCCACTTA |